In this report, we characterize the biological and biochemical properties of a conditional protein containing chicken c-Rel fused to the hormone-binding domain of the human estrogen receptor. This chimeric c-RelER protein causes estrogen-dependent, but otherwise c-Relspeci®c, transformation of avian ®broblasts in vitro. Our results demonstrate that c-RelER heterodimerizes with wild-type c-Rel and forms speci®c complexes with IkB-a. Estrogen causes translocation of c-RelER to the nucleus and stabilizes its binding to DNA. Hormone-activated cRelER induces transcription of at least four cellular genes that are constitutively active in wild-type c-Reltransformed ®broblasts. Two distinct cell populations were examined that diered with respect to their growth phenotypes. The growth of ®broblasts with moderate expression levels of c-RelER was stimulated by estrogen. In contrast, the addition of estrogen to cells with high cRelER expression levels resulted in inhibition of cytokinesis and the arrest of growth. The carboxy terminal transactivation domain of c-Rel was required for the induction of these eects since neither v-Rel nor c-Rel deletion mutants were able to induce similar changes. Taken together, our results demonstrate that high levels of c-Rel expression can aect cell cycle control and/or cytokinesis. Furthermore, they also indicate that the biological properties of c-Rel in cell growth and dierentiation will potentially dier depending on the level of expression.
Introduction
The c-rel proto-oncogene encodes a sequence-speci®c transcription factor whose expression is largely restricted to hematopoietic organs. Recent studies indicate that c-Rel plays a critical role in regulation of B lymphocyte proliferation and T-cell activation (Kontgen et al., 1995 , Gerondakis et al., 1996 . Structurally, c-Rel belongs to a larger family of transcription factors, the Rel/NF-kB family, which also includes RelA, RelB, NF-kB1, NF-kB2, Dorsal, Dif, and Relish. All members of this family are related through a conserved amino-terminal region, the Rel homology domain. This region is responsible for several properties of the proteins, including the formation of homo-and heterodimers, nuclear localization, DNA binding, and interactions with the family of inhibitor proteins, the IkB family (reviewed in Siebenlist et al., 1994; Baeuerle and Henkel, 1994) . A broad range of stimuli, such as cytokines, lipopolysaccharides or phorbol esters, promotes translocation of the Rel proteins from the cytoplasm to the nucleus by mechanisms involving phosphorylation and subsequent degradation of IkB-a (Ghosh and Baltimore, 1990; Brown et al., 1993; Henkel et al., 1993; Beg et al., 1993) . Most members of the Rel/NF-kB family have been implicated in the transcriptional regulation of genes involved in immunoregulatory processes, cell growth, and dierentiation (for a recent review see Baeuerle and Baltimore, 1996) . Consistent with these ®ndings, c-Rel has been implicated in the transcriptional regulation of genes encoding cell adhesion molecules, growth factors such as GM-CSF, interleukin-2 and 3, and their receptors (Kontgen et al., 1995; Gerondakis et al., 1996) .
Alterations in several members of the Rel/NF-kB family have been associated with hematopoietic malignancies (Gilmore et al., 1996) . However, c-Rel and its mutated viral homolog, v-Rel, are the only members of the family consistently shown to be oncogenic in vivo (Gilmore et al., 1996) . Moreover, depending on the cell type, overexpression of c-Rel can lead either to transformation or programmed cell death (Abbadie et al., 1993) . The mechanisms of these processes remain unclear, although most data available to-date indicate that they result from aberrant gene expression induced by Rel (Gilmore et al., 1996) .
In order to more fully understand the mechanisms of c-Rel action and its transforming potential, we constructed an inducible form of c-Rel by fusing it to the hormone-binding domain of the human estrogen receptor (ER). Several functional properties of the protein were investigated, including subcellular localization, DNA binding, and activation of transcription of cellular genes. Using the inducible c-RelER system proliferation properties of cells were examined which correlated with high levels of c-Rel expression. We show that overexpression of c-Rel in ®broblasts results in the generation of cells with characteristic¯attened morphology and dramatically decreased growth rates. Accumulation of these cells in the G1 phase and an extensive breakdown of cellular cytoskeleton suggest that high levels of c-Rel expression can aect cell cycle control and/or cytokinesis. The carboxy terminal transactivation domain of c-Rel is required for the induction of the above eects since neither v-Rel nor a c-Rel carboxy terminal deletion mutant were able to inhibit cell growth and induce similar morphological changes. Taken together, these results indicate that the biological properties of c-Rel in cell growth and dierentiation will potentially dier depending on the level of expression. Utilization of the conditional c-Rel variant described here may help in understanding the changes that accompany altered Rel expression in dierent cell types.
Results

Construction of c-RelER
To generate a conditional c-Rel protein, chicken c-rel sequences were fused in-frame to the hormone-binding domain of the human estrogen receptor (ER). The cRelER construct was subcloned into the polylinker region of the pCRNCM avian retroviral vector, downstream of the CMV promoter (see Figure 1a) . Other retroviral constructs used in this work encoded wild-type c-Rel; Dc-Rel, a truncated version of c-Rel lacking 103 amino acid residues of the carboxyterminal transactivation domain; Dc-RelER, in which Dc-Rel sequences were fused to the hormone-binding domain of the human estrogen receptor; v-Rel and vRelER.
Western blot analysis of protein lysates prepared from pCRNCM-c-RelER-transfected CEF (in the following referred to as c-RelER ®broblasts) showed that the cells expressed the c-RelER protein of the predicted size (100 kDa, Figure 1b) . Similarly, CEF transfected with Dc-Rel, Dc-RelER, v-Rel and vRelER expressed high levels of the corresponding proteins.
Expression of c-RelER in chicken embryo ®broblasts
Previous studies have shown that overexpression of cRel morphologically transforms primary avian fibroblasts and confers a distinctive phenotype on these cells, characterized by altered morphology, extensive disruption of cellular cytoskeleton, and an extended life span (Abbadie et al., 1993; Kralova et al., 1994) . To determine if expression of c-RelER induces a similar phenotype, c-RelER ®broblasts were grown in the presence or absence of estrogen. The cells grown in the absence of estrogen were morphologically indistinguishable from control pCRNCM-transduced CEF (Figure 2a ). In contrast, most c-RelER ®broblasts grown in the presence of estrogen displayed characteristic fusiform morphology, which became evident within 48 h after the addition of estrogen. This phenotype could be reversed upon addition or withdrawal of hormone. Fibroblasts expressing Dc-RelER exhibited similar estrogen-dependent morphological changes (Figure 2a) .
The morphological alterations of c-RelER CEF correlated with changes in other parameters characteristic of c-Rel-induced phenotype, namely actin bundle breakdown and altered cell growth. As shown in Figure 2b , well-de®ned actin bundles were observed in control pCRNCM-transduced cells and in c-RelER ®broblasts grown in the absence of estrogen. In contrast, c-RelER CEF grown in the presence of estrogen exhibited extensive breakdown of actin bundles. Similar disruption of cellular cytoskeleton was found in wild-type c-Rel or v-Rel-expressing ®broblasts. 
Subcellular localization of c-RelER
Immuno¯uorescent staining of cells using a Rel-speci®c antibody revealed that in the absence of estrogen, both c-RelER and Dc-RelER were localized in the cytoplasm. Estrogen induced translocation of the chimeric proteins from the cytoplasm to the nucleus (see Figure 3 ). Similar hormone-dependent properties were previously reported for v-RelER and v-MybER (Burk and Klempnauer, 1991; Boehmelt et al., 1992; Capobianco and Gilmore, 1993) . The phenotype of cRelER ®broblasts was also analysed in response to two estrogen analogs, 4-hydroxytamoxifen (OHT) and ICI 164,384 (ICI). OHT and ICI behave as a partial estrogen agonist and antagonist, respectively, for the authentic estrogen receptor (Wakeling and Bowler, 1988) . Both OHT and ICI induced a shift of the chimeric proteins to the nucleus, although ICImediated translocation was markedly weaker in all cells tested (see Figure 3g ). Similar results were obtained when cytoplasmic and nuclear extracts were analysed by Western blotting (data not shown). In contrast to these results, the predominantly cytoplasmic localization of wild-type c-Rel did not change upon addition of estrogen. It was also unresponsive to OHT and ICI. These results indicate that fusion to the estrogen-binding domain may block the cytoplasmic retention signal contained in the carboxy terminal part of c-Rel. Thus, Dc-Rel which lacks this region, is constitutively nuclear (see Figure 3c ). Since there is no nuclear localization signal in the hormone-binding domain of the estrogen receptor (Green and Chambon, 1991) , perhaps the nuclear localization sequence present in Rel-homology domain is involved in the shift of chimeric proteins to the nucleus (Capobianco and Gilmore, 1993) . It is likely that the addition of hormone initiates conformational changes and thus triggers subsequent translocation of both c-RelER and Dc-RelER to the nucleus.
Complexes of c-RelER with other proteins
To determine if c-RelER forms complexes with the same set of proteins as wild-type c-Rel,
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S-labeled lysates prepared from c-RelER ®broblasts were examined by direct immunoprecipitation using two types of antibodies: SB66 Rel-speci®c antibody, and HC20 antibody directed against the hormone-binding domain of the human estrogen receptor. This analysis revealed that c-RelER forms heterodimeric complexes with endogenous c-Rel (Figure 4 ). Similar amounts of c-Rel were coprecipitated from cells grown in the presence or absence of estrogen, indicating that dimerization of c-RelER with wild-type c-Rel does not depend on hormone-activation of c-RelER. In addition, a 36 kDa protein, which has been identi®ed as IkB-a in previous works (Tung et al., 1988; Davis et al., 1991) , is speci®cally complexed with both wild-type c-Rel and c-RelER (Figure 4 , lanes 3, 7 and 9). Interestingly, proportional quantities of IkB-a were coprecipitated by anti-Rel sera from the cells overexpressing wild-type c-Rel or estrogen-activated cRelER. However, the ability of c-RelER to form complexes that include IkB-a was reduced in the absence of estrogen or in the presence of its structural analogs.
c-RelER binds to NF-kB sites in vitro
To examine the DNA binding properties of c-RelER, nuclear and cytoplasmic extracts prepared from cRelER CEF were analysed by mobility shift assays with a radiolabeled oligonucleotide that included an NF-kB binding site contained in the promoter of the chicken IkB-a gene. This region of the Ik-a gene exhibits speci®c binding anity with c-Rel (Schatzle et al., 1995) . As can be seen in Figure 5 , nuclear extracts prepared from control CEF showed low binding activity ( Figure 5a , lane 2; Figure 5b , lane 2). In contrast, multiple protein-DNA complexes were observed in nuclear and cytoplasmic extracts prepared from c-RelER ®broblasts grown in the presence of estrogen ( Figure 5a , lanes 4 and 6). The cytoplasmic extracts contained less DNA binding activity ( Figure  5a , lanes 5 and 6), and protein-DNA complexes migrated more slowly in the gel, suggesting associations of c-RelER with other proteins present in the cytoplasm. A mutated NF-kB site was included in reactions as a control for the speci®city of DNA binding. The speci®c bands disappeared when the mutated oligonucleotide was used ( Figure 5a , lanes 7 ± 10). Similar results were obtained when the DNA binding reactions were preincubated with the Relspeci®c antibody. As expected, the intensity of Relspeci®c bands was drastically reduced in extracts prepared from c-RelER cells grown in the absence of estrogen. Similarly, the cytoplasmic and nuclear extracts prepared from cells maintained in OHT or ICI reproducibly showed less activity than the equivalent extracts from estrogen-treated cells.
Transcriptional activity of c-RelER
To test the ability of c-RelER protein to activate gene expression, transient transfection experiments were performed. The CMV-luc reporter plasmid used for this purpose contains four NF-kB-binding sites in its promoter region. The reporter plasmid and Rel constructs subcloned into the RSV-script expression vector (see Materials and methods) were cotransfected into QT6 quail ®broblasts. Following transfection, luciferase activity was measured in cells maintained in the presence or absence of estrogen. As shown in Table  1 , the expression of wild-type c-Rel and estrogenactivated c-RelER and Dc-RelER resulted in threefold induction of luciferase activity, whereas expression of Dc-RelER resulted in about sixfold induction. While relatively low levels of induction were probably due to high basal levels of transcription from the reporter construct, OHT and ICI were less potent activators of both c-RelER and Dc-RelER under these experimental conditions.
Eect of c-RelER on expression of cellular genes
We next investigated the eect of c-RelER on transcriptional activation of cellular genes. Three genes were initially examined, those encoding the cytoplasmic inhibitor IkB-a, a cell surface antigen Sca-2, and a chicken homologue of the mammalian macrophage in¯ammatory protein-1 beta (Mip-1b). Previous studies established that these genes are constitutively activated in c-Rel-transformed fibroblasts and v-Rel-transformed hematopoietic cells (Kralova et al., 1994; Petrenko et al., 1997) . This study allowed us to correlate the transformationspeci®c alterations of c-RelER ®broblasts with the transcriptional activity of the chimeric protein.
As can be seen in Figure 6 , estrogen-activated c-RelER induced the expression of all tested genes. In contrast, OHT and ICI failed to induce the expression of these genes. By examining several other genes with kB sites in their promoter regions, we found that the gene encoding 9E3/CEF4, an avian homolog of the human interleukin-8, was inducible by estrogen in cRelER CEF. This induction was also found in c-Rel expressing CEF (lanes 3 and 9), but not in v-Reltransformed ®broblasts and hematopoietic cells (lane 15 and data not shown). One aspect of the lack of CEF4 activation by v-Rel is that it was present at low levels in control CEF maintained in estrogen (lane 1), and activated to some extent by v-RelER in the presence of estrogen (lanes 15 ± 17). This might suggest that the ER domain confers some type of gene-speci®c activation to v-Rel and c-Rel. However, examination of c-Rel CEF generated with the use of two dierent retroviral vectors, pCRNCM and RCAS, showed that they express 9E3/CEF4 irrespective of the presence of estrogen (data not shown). Thus, the expression of 9E3/CEF4 appears to be c-Rel but not v-Rel-speci®c.
Growth phenotypes of individual CEF clone lineages
Analysis of CEF clones expressing dierent levels of cRelER revealed two distinct cell populations that (7) with estrogen, were incubated with the oligonucleotide containing a wild-type NF-kB sequence present in the promoter region of the IkB-a gene (lanes 1 ± 6) or a mutated NF-kB sequence (lanes 7 ± 10). Lanes 4, 6, 9 and 10 contain extracts from estrogen treated CEF. (b) Nuclear extracts from untransfected CEF (lanes 2 and 3) or c-RelER CEF grown in the absence of estrogen (lanes 4 and 5), or in the presence of estrogen (lanes 6 and 7), ICI (lanes 8 and 9), or OHT (lane 10), were incubated with the oligonucleotide containing a wild-type NF-kB sequence in the presence of antiRel antibody (lanes 3, 5, 7, 9), or without antibody added (lanes 1, 2, 4, 6, 8 and 10). Lane 1 contains no extract To determine if overexpression of wild-type c-Rel induced similar response, the growth phenotypes of pCRNCM-c-Rel CEF were analysed in more detail. Protein lysates prepared from RCAS-c-Rel CEF were used as controls for a comparison of c-Rel expression levels in pCRNCM-c-Rel clones. While the majority of pCRNCM-c-Rel CEF expressed c-Rel at levels equivalent or lower to those found in RCAS-c-Rel CEF, a proportion of clones expressed the protein at 2 ± 3-fold higher levels (data not shown). The growth rates of such cells were extremely low compared to clones with lower levels of c-Rel expression (see Table  2 ). In addition, these cells were characterized by large size,¯attened`nonfusiform' morphology (Figure 7a) , and signi®cantly shortened life span. Again, at least 40% of such cells were binuclear (data not shown). These results indicate that high levels of c-Rel expression could interfere with cell cycle progression. To determine if this is the case, pCRNCM-c-Rel CEF were further analysed by¯ow cytometry. The results obtained with three representative clone lineages are shown in Figure 7b . Typically, the majority of control untransfected CEF contain a 2C DNA content as expected for cells in the G0/G1 phase, while the rest of the cells contain 4C amount of DNA, characteristic of G2/M cells. While CEF expressing low levels of c-Rel revealed a slight increase in cell number with 4C DNA content (Figure 7b ), CEF expressing high levels of c-Rel showed a dramatic shift in DNA content distribution with the majority of cells having the 4C DNA content. As can be seen in Figure 7b , such cells were assigned by a curve ®tting program to G2/M phase of the cell cycle. The presence of a large proportion of binuclear cells correlated with the number of cells with the 4C DNA and suggested that high expression levels of c-Rel inhibited cytokinesis, rather than mitosis, and that the examined cells were arrested in G1 phase. Interestingly, we did not observe a pre-G1 peak indicative of cells undergoing apoptosis. No cells expressing high cRel levels were assigned to S phase con®rming that these cells were not replicating their DNA. Thus, the results indicate that the proportion of cells with the 4C DNA content, their morphology, and growth rates correlated with the levels of exogenous c-Rel expression.
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rRNA 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Proliferation of CEF was measured in DMEM supplemented with 8% fetal calf serum and 2% chick serum. Relative levels of c-Rel expression were estimated by Western blot analyses of protein extracts using a Rel-speci®c antibody SB66. pCRNCMc-Rel CEF were selected, expressing c-Rel at levels equivalent to those in RCASc-Rel-infected CEF (++) or a two-to three-fold higher levels (+++)
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Discussion
In this report, we characterize the biological and biochemical properties of a conditional protein containing c-Rel fused to the hormone-binding domain of the human estrogen receptor (c-RelER). This chimeric protein causes estrogen-dependent, but otherwise c-Rel-speci®c, transformation of avian ®broblasts in vitro. In order to understand the mechanisms of c-RelER action, dierent functional properties of the protein were investigated, including subcellular localization, DNA binding, and activation of transcription of cellular genes. Our analysis revealed that in the absence of estrogen, c-RelER was found predominantly in the cytoplasm, while the hormone and its structural analogs, OHT and ICI, induced a shift of the cRelER protein to the nucleus. Hormone activation of c-RelER had little eect on its ability to form homoor heterodimers. Thus, c-RelER coimmunoprecipitated with c-Rel in the presence or absence of estrogen. In contrast, association of c-RelER with IkB-a, the inhibitor molecule, was stronger in the presence of estrogen. Similar amounts of IkB-a were coprecipitated by anti-Rel sera from the cells overexpressing estrogenactivated c-RelER or wild-type c-Rel. Furthermore, cRelER exhibited the same target sequence speci®city as c-Rel. The DNA-binding activity of c-RelER was signi®cantly higher in extracts prepared from cells grown in the presence of estrogen. Although this dierence may be ascribed to higher levels of c-RelER in the nuclei of hormone-stimulated cells, the addition of estrogen directly to the DNA-binding reaction resulted in a corresponding increase of binding activity (data not shown). Thus, in the absence of estrogen, cRelER remains inactive, while in the presence of estrogen, hormone-activated protein forms stable complexes with DNA.
In correlation with these results, transient transactivation of CMV-luc reporter constructs revealed increased luciferase activity in cells transfected with wild-type c-Rel or hormone-activated c-RelER. In addition, at least four cellular genes that are constitutively active in c-Rel-transformed cells, Sca-2, MIP-1b, IkB-a and 9E3/CEF4, were up-regulated in c-RelER ®broblasts in a hormone-responsive fashion. This ®nding supports the conclusion that c-RelER is a conditional version of c-Rel. We previously reported that three of these genes, Sca-2, MIP-1b, and IkB-a, are also up-regulated in v-Reltransformed ®broblasts and hematopoietic cells (Petrenko et al., 1997) . Interestingly, most genes identi®ed so far as v-Rel targets are also upregulated in cells transformed by c-Rel. However, the kinetics and relative levels of their expression dier in each case. Thus, v-Rel induces higher levels of MHC class I and II, IL-2R, DM-GRASP and p75 in lymphoid cells (HrdlicÏ kovaÂ et al., 1995 Zhang et al., 1995; Zhang and Humphries, 1996) , while c-Rel induces higher levels of NF-kB1, IkB-a, and c-myb in lymphoid cells and ®broblasts (HrdlicÏ kovaÂ et al., 1995; Petrenko et al., 1997) . Consistent with these results, v-Rel and Dc-Rel appear to be stronger activators of IkB-a and Mip1b expression in the transformed ®broblasts, while cRel induced higher levels of Sca-2 and 9E3/CEF4.
Using the inducible c-RelER system, proliferation properties of cells were examined that correlated with high levels of c-Rel expression. Previous works have shown that overexpression of c-Rel confers a distinctive phenotype on primary avian ®broblasts, characterized by altered morphology, disruption of cellular cytoskeleton, and a remarkably extended life span (Abbadie et al., 1993; Kralova et al., 1994) . CEF expressing c-RelER normally also displayed altered morphology, decreased amounts of actin bundles, and life span characteristic of c-Rel-transformed CEF. Two distinct cell populations were analysed which diered with respect to their growth phenotypes. While the growth of ®broblasts that exhibited moderate expression levels of c-RelER was stimulated by estrogen, the addition of estrogen to cells with high levels of cRelER expression resulted in decreased cell growth or ultimate growth arrest. Such cells adopted large, attened morphology typical of senescing cells. In addition, about 40% of them were binuclear and had no F-actin detectable. The carboxy terminal transactivation domain of c-Rel was required for the induction of these eects. Thus, neither Dc-Rel nor v-Rel were able to inhibit cell growth and induce similar morphological changes in ®broblasts. In contrast, high levels of c-Rel expression reproducibly resulted in the generation of cells with¯attened morphology and dramatically decreased growth rates. Cell division did not occur and a large proportion of c-Relexpressing cells were binuclear and had a 4C DNA content. Our preliminary analysis did not reveal the characteristic apoptotic DNA ladder typical of cells undergoing programmed cell death. Accumulation of these cells in G1 phase and an extensive breakdown of cellular cytoskeleton rather suggested that overexpression of c-Rel aected cell cycle control and/or cytokinesis. Our results are in agreement with previous studies which showed that high levels of c-Rel expression can aect cell cycle in bone marrow and HeLa cells (Abbadie et al., 1993; Baeuerle and Baltimore, 1996) , or have a cytotoxic/cytostatic eect in transformed B-cell lines . Thus, these results suggest a critical role for c-Rel not only in the control of cell proliferation but also in the induction of cell death. Furthermore, indicated by these ®ndings the biological properties of c-Rel in cell growth and dierentiation potentially dier depending on the level of expression. Utilization of the conditional c-Rel variant described here may help in understanding the changes that accompany altered Rel expression in dierent cell types.
Materials and methods
Plasmids and constructs
Construction of c-RelER The chicken c-rel cDNA (amino acid residues 1 ± 598, Capobianco et al., 1990) , and the hormone-binding domain of the human estrogen receptor (ER, amino acid residues 282 ± 595) contained in the BamHI ± SacI fragment of HE14 (Kumar et al., 1986) , were subcloned in-frame into the pBluescript SK + vector (Stratagene). The stop codon in c-rel and an internal ClaIsite of the chimeric construct were subsequently removed by site-directed mutagenesis without changing the amino acid coding to generate c-relER. The construct was completely sequenced to ensure that no unexpected mutations were introduced. A truncated version of c-rel, Dc-rel, was generated by deleting 103 carboxy-terminal codons from the c-rel cDNA. DcrelER contains the ER domain of the human estrogen receptor fused to Dc-Rel (which has a deletion of 101 carboxy-terminal amino acids from wild-type c-Rel). v-Rel and v-RelER constructs were described earlier (Morrison et al., 1991 , Boehmelt et al., 1992 . All constructs were subcloned into the ClaI site of the pCRNCM-neo replication-defective avian retroviral vector (Metz et al., 1991) , downstream of the immediate early CMV promoter. In addition RCAS-c-Rel construct (Abbadie et al., 1993) containing full-length c-Rel sequence subcloned into pRCAS (Hughes et al., 1987) was used as a control.
Reporter plasmids The CMV-luc reporter plasmid was constructed by subcloning of the CMV promoter region containing four putative NF-kB binding sites (nucleotides 7671 to +77, Boshardt et al., 1985) derived from pCRNCM-neo into the BglII site of pGL2 basic vector (Promega). The SV40-gal plasmid was kindly provided by Dr D Bar-Sagi, Stony Brook, NY. To generate the RSVscript expression vector, the SalI fragment of pREP7 (Invitrogen), containing the RSV promoter and the SV40 polyadenylation signal, was blunt-ended and subcloned into the KpnI/SacI-digested and blunt-ended pBluescript SK + DNA. ClaI restriction site was subsequently inserted into RSV-script by replacing the original 17 bp HindIII ± XhoI fragment of pRep7 polylinker with 21 bp HindIII ± XhoI fragment from pBluescript SK + polylinker. The Rel cDNAs were subcloned into ClaI site of the RSV-script vector using conventional techniques.
Cell culture and DNA transfection
Cells were maintained in DMEM supplemented with 8% fetal calf serum and 2% chicken serum. Estrogen (17-bestradiol, Sigma) and ICI 146,384 (ICI Pharmaceuticals) were used at a ®nal concentration 10 76 M. 4-hydroxytamoxifen (OHT, Aldrich) was used at a concentration 2610 77 M. Chicken embryo ®broblasts (CEF) were prepared from 6-to 7-day-old embryos as described (Vogt, 1969) . QT6 is a transformed quail ®broblast cell line (Moscovici et al., 1977) . Avian ®broblasts expressing recombinant viruses were prepared using calcium-phosphate/DNA transfection protocol (Chen and Okayama, 1987) . Transfected cells were selected in G418 (200 mg/ml), and characterized for Rel expression levels by Western blot analysis. Individual CEF clones were further used for the characterization of growth phenotypes. For other purposes, typically up to ®ve clones were pooled and maintained in G418 (40 mg/ml).
Growth rate analysis and¯ow cytometry
Proliferation of ®broblasts was measured by direct counting of trypsinized cells using a Coulter counter. All values represent an average of three experiments. Standard deviation of estimates did not exceed 10%. For¯ow cytometry analysis, CEF were grown to 70% con¯uence. 5610 5 nonsynchronized cells were collected, ®xed in 70% ethanol, incubated with RNase A, and stained with propidium iodide as described (Vindelov et al., 1983) . Fluorescence of nuclei was measured in FACScan (Becton Dickinson) and analysed with the MacCycle curve ®tting program for DNA content and cell cycle analysis (Phoenix Flow Systems, Inc.).
Transient transfection assay
Semicon¯uent QT6 cells were transfected with plasmid DNAs in 60 mm plates using the calcium phosphate transfection protocol. 5610 5 cells were co-transfected with 2.5 mg of RSV-script-Rel together with 0.8 mg of CMV-Luc reporter plasmid and 1.5 mg of SV40 b-gal plasmid was used as an internal control. pBluescript plasmid DNA was added to each reaction to bring the total amount of DNA to 7 mg. The cells were incubated in contact with the calcium phosphate precipitate for 16 h, followed by a complete medium change. Three hours later, cells were trypsinized, split into three 60 mm plates, and incubated in the presence or absence of hormone. Fortyeight hours post-transfection cells were harvested, and luciferase activity was determined following the manufacturer's instructions (Promega). The values obtained were normalized with respect to the levels of b-galactosidase activity.
Immunoblot analysis
Protein lysates were prepared and analysed by Western blot analysis as previously described (Morrison et al., 1989) . The following two antibodies were used, SB66, a rabbit polyclonal antibody raised against bacteriallyexpressed trpE-v-Rel fusion protein, is also able to recognize c-Rel (Schwarz and Witte, 1988; Morrison et al., 1989) ; HC-20, a rabbit polyclonal antibody raised against the hormone-binding domain of the human estrogen receptor (Santa Cruz Biotechnology).
Immunoprecipitations CEF were preincubated in methionine-and cysteine-free medium and labeled with 35 S-trans Label (Amersham) for 2 h. Cells were lysed in 0.5% NP40, 0.5% deoxycholate, 20 mM Tris-HCl, pH 8.0, 50 mM NaCl and subjected to immunoprecipitation analysis using the Rel-speci®c SB66 antibody, and HC-20, a rabbit polyclonal antibody raised against the hormone-binding domain of the human estrogen receptor (Santa Cruz Biotechnology), as previously described (Morrison et al., 1989) . Immunoprecipitates were analysed by SDS ± PAGE.
Immuno¯uorescent staining
Fibroblasts were grown on coverslips, washed in PBS, and ®xed in 3% paraformaldehyde for 15 min. Cells were subsequently permeabilized by incubation in 0.5% NP40 in phosphate-buered saline (PBS) for 15 min and washed three times with 0.5% bovine serum albumin (BSA) in PBS. For immuno¯uorescence staining, cells were incubated with the SB66 antibody (diluted 1:20), for 1 h at 378C. Cells were washed three times with 0.5% BSA in PBS and incubated with a 1:200 dilution of FITCconjugated goat anti-rabbit IgG for 45 min at 378C. Following extensive washing in PBS, cells were mounted in Gel/mount (Biomeda corp.). To stain actin cables, cells were incubated with rhodamine-conjugated phalloidin following the instructions of the manufacturer (Molecular Probes).
Gel-mobility shift assays
Nuclear or cytoplasmic extracts from c-Rel or c-RelER cells grown in the presence or absence of hormone were prepared as described by Dignam et al. (1983) . Oligonucleotides contained the sequence present in the promoter region of the chicken IkB-a gene (Schatzle et al., 1995) : an NF-kB-2 wild-type sequence, 5'-TGCAGTTAATGG-GAATCCCCCGCAT-3', and a mutated NF-kB-2 sequence, 5'-TGCAGTTAATGAAGATCCCCCGCAT-3'. The double-stranded oligonucleotides were labeled using Klenow DNA polymerase and a 32 P-dATP. 8 mg of the corresponding nuclear or cytoplasmic extracts were c-Rel-estogen receptor fusion protein M Zurovec et al incubated 15 min at room temperature with 10 000 c.p.m. of 32 P-labeled oligonucleotide in a ®nal reaction volume of 30 ml. Incubation buer contained 25 mM HEPES, pH 7.5, 1 mM DTT, 1 mM EDTA, 15% glycerol and 1 mg of poly [dA-dT] .
For supershift analysis, the extracts were preincubated with the SB66 antibody for 15 min on ice prior to the addition of the labeled oligonucleotide. Reactions were then analysed by electrophoresis in 5% native polyacrylamide gels as described (Kabrun et al., 1991) .
RNA isolation and Northern analysis
The CEF from 3 ± 5 pooled clone lineages were grown 30 ± 35 days after transfection in the culture and used for total RNA isolation by the lithium chloride-urea procedure of Auray and Rougeon (1980) . RNA aliquots (7 mg) were separated by formaldehyde-agarose gel electrophoresis and transferred to Hybond-N nylon membranes (Amersham). The membranes were stained in 1% methylene blue to verify the integrity of rRNA bands. Hybridization and washing conditions were as described in Church and Gilbert (1984) . Hybridization probes were prepared by random priming of gel-puri®ed c-DNA inserts. The cDNAs encoding chicken MIP-1b and Sca-2 were isolated in this laboratory (Petrenko et al., 1995 , Petrenko et al., 1997 .
1 kb 9E3/CEF-4 cDNA was kindly provided by Prof H Hanafusa and described in Sugano et al. (1987) . Chicken IkB-a cDNA was kindly provided by Dr IM Verma.
Note added in proof
Recent studies on HeLa cells demonstrated that the expression of c-Rel leads to growth arrest at the G1/Sphase transition. See Bash et al. (1997) . Mol. Cell. Biol. 17, 6526 ± 6536
